Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln - Reuters


12/22/2023

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln  ReutersKaruna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal  CNBCBristol Myers to buy Karuana for $14 billion  The Boston GlobeBristol Myers buying schizophrenia drug developer Karuna for $14 billion  AxiosKRTX Stock Soars On Bristol Myers' $14 Billion Takeover  Investor's Business Daily...

Original

Tags: announces | billion | boston | business | buy | daily | developer | drug | reuters | stock



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top